CompuMed Q2 revenues slip

Bone densitometry software developer CompuMed reported fiscal second-quarter revenues of $461,000, down 4.4% compared with the $482,000 booked in the same period last year.

For the quarter (end-March 31), the Los Angeles-based firm had a net loss of $79,000, compared with a net loss of $59,000 a year ago. The company said it has continued to shift towards the development of applications for DICOM-compliant medical imaging equipment.

By staff writers
May 17, 2004

Related Reading

CompuMed starts DICOM OsteoGram shipments, April 22, 2004

CompuMed nets second OsteoGram patent, March 13, 2004

CompuMed, eTrauma ink deal, March 9, 2004

CompuMed revenues up, losses down in Q1, February 17, 2004

CompuMed signs for credit line, January 12, 2004

Copyright © 2004

Page 1 of 374
Next Page